LDN Insights with Dr. Yusaf (PJ) Saleeby
Dr. Yusaf (PJ) Saleeby shares insights from his practice in 2025 regarding Low Dose Naltrexone (LDN). He discusses patient sensitivity, optimal starting doses, and LDN's efficacy for various conditions including Lyme, cancer, and autoimmune diseases. The conversation also delves into Mast Cell Activation Syndrome (MCAS) and the critical role of informed clinicians in its management.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The LDN Radio Show About Low Dose Naltrexone
Personalized Health with LDN - JJ Allen, PharmD
LDN for Neuropathy and Pain by Deborah
LDN: Innovations in Autoimmune Treatment - Dr Leonard Weinstock, MD
Dr Marina OBGYN Radio Show Interview
Get summaries like this every morning.
Free AI-powered recaps of The LDN Radio Show About Low Dose Naltrexone and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.